Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHPA1.L Regulatory News (HPA1)

  • There is currently no data for HPA1

Directorate Change

14 Apr 2023 12:55

RNS Number : 3042W
Hambro Perks Acquisition Com Ltd
14 April 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS IS AN ANNOUNCEMENT AND NOT AN OFFER TO SELL OR AN INVITATION TO PURCHASE OR SUBSCRIBE FOR ANY SECURITIES NOR A CIRCULAR OR PROSPECTUS OR EQUIVALENT DOCUMENT AND INVESTORS OR PROSPECTIVE INVESTORS SHOULD NOT MAKE INVESTMENT DECISIONS ON THE BASIS OF ITS CONTENTS.

FOR IMMEDIATE RELEASE.

14 April 2023

Hambro Perks Acquisition Company Limited

Resignation of Director

Hambro Perks Acquisition Company Limited (LSE: HPA1) ("HPAC" or the "Company"), a special purpose acquisition company formed to focus on a Business Combination, announces the resignation of Mr. Dominic Perks as a director with effect from today's date.

The Company continues its search for a Business Combination and looks forward to updating the market in due course.

Enquiries

Hambro Perks Acquisition Company Limited

Peter Soliman, Company Secretary

 

peter@hambroperks.com

Notes to Editors

The information contained in this announcement is deemed by HPAC to constitute inside information for the purposes of Article 7 of the UK Market Abuse Regulation. By the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this announcement on behalf of HPAC is Peter Soliman, Company Secretary.

About HPAC

HPAC is a special purpose acquisition company incorporated as a non-cellular company limited by shares under the laws of the Island of Guernsey with number 69093 and for the purpose of acquiring a majority (or otherwise controlling) stake in a company or operating business through a merger, capital stock exchange, share purchase, asset acquisition, reorganisation or similar transaction. HPAC was admitted to trading on the standard listing segment of the main market for listed securities of the LSE on 30 November 2021.

For further information on HPAC, please see www.hpac.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFELSSISLIV
Date   Source Headline
2nd May 20237:30 amRNSSuspension - Hambro Perks Acquisition Company
14th Apr 202312:55 pmRNSDirectorate Change
6th Apr 20232:52 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSHolding(s) in Company
28th Mar 20234:59 pmRNSHolding(s) in Company
24th Mar 202311:20 amRNSTotal Voting Rights Clarification 24/03/2023
23rd Mar 202312:54 pmRNSVoting Rights Announcement
16th Mar 20235:33 pmRNSResults of Redemption Election
28th Feb 20231:24 pmRNSResults of Extraordinary General Meeting 28 Feb 23
22nd Feb 20232:41 pmRNSUpdate on Timetable for Potential Redemption
10th Feb 20237:00 amRNSNotice of EGM
8th Feb 20235:35 pmRNSHolding(s) in Company
5th Oct 20222:05 pmRNSResults of AGM
14th Sep 20227:00 amRNSFirst Annual General Meeting
25th Aug 20227:00 amRNSHalf-year Report
29th Jun 20227:00 amRNSAnnual Report & Audited Financial Statements
4th May 20224:59 pmRNSChange of Registered Office
11th Jan 20222:13 pmRNSHolding(s) in Company
7th Jan 20228:00 amRNSWarrants Admission to Trading
7th Jan 20227:00 amRNSConfirmation of Public Warrants
17th Dec 20217:00 amRNSConfirmation of Public Warrants Ex Date
10th Dec 20218:00 amRNSOverfunding Shares Admission to Trading
7th Dec 20218:00 amRNSOver-allotment Shares Admission to Trading
6th Dec 20214:59 pmRNSTR-1: Notification of major holdings
6th Dec 20213:59 pmRNSExercise of Over-allotment Option
6th Dec 20212:57 pmRNSTR-1: Notification of major holdings
3rd Dec 20214:38 pmRNSTR-1: Notification of major holdings
3rd Dec 20217:05 amRNSStabilisation Notice
3rd Dec 20217:00 amRNSExercise of Over-allotment Option
30th Nov 20218:00 amRNSShares Admission to Trading on the LSE
25th Nov 202112:23 pmRNSApproval and Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.